Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Shorts

MagazineJuly 1999 (Vol. 10 Issue 4)Shorts

* The FDA has lifted its ban on the diabetes drug troglitazone (Rezulin), deciding that the benefits of the drug outweigh possible risks (Lancet, 1999; 353: 1161)

* The FDA has lifted its ban on the diabetes drug troglitazone (Rezulin), deciding that the benefits of the drug outweigh possible risks (Lancet, 1999; 353: 1161). They caution, however, that the controversial drug, which the Public Citizen's Health Research Group have petitioned to have removed from the US market, should not be considered as a first line in treatment. Troglitazone has been associated with irreversible liver damage in long term users.

* There are calls for better child proof caps and clearer warnings on bottles of mouthwash after a three year old was found comatose and hypothermic after drinking a bottle of "extra strength" mouthwash (BMJ, 1999; 318: 1078). The product, a supermarket own brand, contained 37 per cent alcohol. Seven other paediatric cases of coma after mouthwash ingestion have been recorded in medical literature, two of which were fatal.


Is the soil association really the bad guy over organic meat?

Body and mind

You may also be interested in...

Sign up for free today

Sign up now to get your FREE 17-point Plan to Great Health

Free membership gives you access to our latest news reports, use of our community area, forums, blogs, readers' health tips and our twice-weekly
e-news letter.

WDDTY Recommends

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, cancer, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2016 WDDTY Publishing Ltd.
All Rights Reserved